<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">Tocilizumab has no inhibitory effects on cytochromes. However, tocilizumab reverses IL-6 induced suppression of cytochromes and the elevation of IL-6 during inflammation has been shown to inhibit CYP3A4, CYP2C19, CYP2C9, and CYP1A2 expression, resulting in higher exposure of substrate drugs [
 <xref ref-type="bibr" rid="CR64">64</xref>].
</p>
